A neoadjuvant chemotherapy trial for early breast cancer is impacted by COVID-19: Addressing vaccination and cancer trials through education, equity, and outcomes

David A. Potter, Alexandra Thomas, Hope S. Rugo

Research output: Contribution to journal › Review article › peer-review

5 Scopus citations

Fingerprint

Dive into the research topics of 'A neoadjuvant chemotherapy trial for early breast cancer is impacted by COVID-19: Addressing vaccination and cancer trials through education, equity, and outcomes'. Together they form a unique fingerprint.

Medicine & Life Sciences